This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from 15-17 November 2021
Live In-Person Conference Delivered 15-17 NovemberSheraton Airport Brussels, Belgium

Dieter Willbold, Ph.D.
Director at Forschungszentrum Jülich


Dieter Willbold studied biochemistry in Tübingen (Germany), Bayreuth (Germany) and Boulder (Colorado, USA). He completed his PhD in 1994 at the University of Bayreuth. After some more years in Bayreuth and a couple of research visits, e.g. at the School of Medicine of the Tel-Aviv University, in 1998 he was leading his independent junior research group at the Institute for Molecular Biotechnology in Jena, Germany. In 2001 Willbold became an associate Professor at the Heinrich Heine University in Düsseldorf. Since 2004, he is full professor and chair of the Institute of Physical Biology in Düsseldorf and director of the Institute of Biological Information Processing at the Forschungszentrum Jülich. He is co-founder of spin-off companies, e.g. Priavoid. His main interests are protein interactions with physiological and artificial ligands, high resolution structural biology, aging and neurodegeneration.

Agenda Sessions

  • Clinical Data of the all-D-peptide Alzheimer’s Disease Drug Candidate PRI-002